how common is gastroparesis with semaglutide 🧬 GLP-1s and Gastroparesis: What You Need to Know, GLP-1 receptor agonists (like and tirzepatide) have revolutionized weight management and type 2 diabetes care. But as use has People using popular drugs for

In clinical trials of Wegovy (a semaglutide medication), participants lost an average of 15% of their body weight (approximately 33 pounds, though individual results varied) within 68 weeks

If you want an additional supplement option during your weight loss routine, explore Weight Loss Boost supplement as part of your daily support plan

It does help the metabolism and gives a slight natural energy boost, but the patient must be already committed to a diet and exercise plan

So happy I never have to try and get myself to the pharmacy anymore

Now thats a win

#Pharmacovigilance #MedDRA #DrugSafety #OpenVigil #FAERS #MedicationErrors #DataVisualization To view or add a comment, sign in As pharmacogenomics moves from bench to bedside, the scope of druggene evidence has exploded